Rifadin and lymphocytic infiltration Patient Reports February 12, 2012
Rifadin Side Effects Report #4626734-1
Rifadin side effect was reported by a Consumer or non-health professional from on Mar 25, 2005. Female patient, child 12 years of age, was treated with Rifadin. After drug was administered, patient experienced the following side effects: angioneurotic oedema, cheilitis, eosinophilia, hepatocellular damage, lymphadenopathy, lymphocytic infiltration, neutropenia, purpura. Rifadin dosage: unknown. During the same period patient was treated with AMIKACIN, TAZOCILLINE, TRIFLUCAN, VANCOMYCIN. Patient was hospitalized. Patient recovered.
Rifadin Side Effects Report #4635990-5
Rifadin side effect was reported by a Consumer or non-health professional from on Mar 25, 2005. Female patient, child 12 years of age, was treated with Rifadin. After drug was administered, patient experienced the following side effects: angioneurotic oedema, cheilitis, eosinophilia, hepatocellular damage, lymphadenopathy, lymphocytic infiltration, neutropenia, purpura. Rifadin dosage: unknown. During the same period patient was treated with AMIKACIN, TAZOCILLINE, TRIFLUCAN, VANCOMYCIN. Patient was hospitalized. Patient recovered.
Rifadin Side Effects Report #4811120-1
Rifadin side effect was reported by a Consumer or non-health professional from on Mar 25, 2005. Female patient, child 12 years of age, was treated with Rifadin. After drug was administered, patient experienced the following side effects: angioneurotic oedema, cheilitis, eosinophilia, hepatocellular damage, lymphadenopathy, lymphocytic infiltration, neutropenia, purpura. Rifadin dosage: unknown. During the same period patient was treated with AMIKLIN, TAZOCILLINE, TRIFLUCAN, VANCOCIN. Patient was hospitalized. Patient recovered.
Rifadin Side Effects Report #5034055-0
Rifadin side effect was reported by a Consumer or non-health professional from on Mar 25, 2005. Female patient, child 12 years of age, was treated with Rifadin. After drug was administered, patient experienced the following side effects: angioneurotic oedema, cheilitis, eosinophilia, hepatocellular damage, lymphadenopathy, lymphocytic infiltration, neutropenia, purpura. Rifadin dosage: unknown. During the same period patient was treated with AMIKLIN, TAZOCILLINE, TRIFLUCAN, VANCOCINE. Patient was hospitalized. Patient recovered.
Rifadin and lymphocytic infiltration 